Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00164736Phase 3Completed
A Phase 3 trial of zidovudine + lamivudine + lopinavir/ritonavir, nevirapine in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Mar 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00164736.